Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses

Iliès Benotmane, Gabriela Gautier, Peggy Perrin, +4

JAMA

Is COVID-19 infection more severe in kidney transplant recipients?

Sophie Caillard, Nathalie Chavarot, H. François, +34

American Journal of Transplantation

Cytokine release syndrome‐associated encephalopathy in patients with COVID‐19

Peggy Perrin, Nicolas Collongues, Seyyid Baloglu, +10

European Journal of Neurology

Antibody Response to a Fourth Messenger RNA COVID-19 Vaccine Dose in Kidney Transplant Recipients: A Case Series

Sophie Caillard, Olivier Thaunat, Iliès Benotmane, +2

Annals of Internal Medicine

In-depth virological assessment of kidney transplant recipients with COVID-19

Iliès Benotmane, Gabriela Gautier-Vargas, Marie-Josée Wendling, +21

American Journal of Transplantation

Infection or a third dose of mRNA vaccine elicits neutralizing antibody responses against SARS-CoV-2 in kidney transplant recipients

Xavier Charmetant, Maxime Espi, Iliès Benotmane, +20

Science Translational Medicine

Cerebrospinal Fluid Features in Patients With Coronavirus Disease 2019 and Neurological Manifestations: Correlation with Brain Magnetic Resonance Imaging Findings in 58 Patients

François Lersy, Iliès Benotmane, Julie Helms, +16

The Journal of Infectious Diseases

Viral DiagnosticsImmunologyClinical NeurologyCsf AnalysisCovid-19 +16

Breakthrough COVID-19 cases despite prophylaxis with 150 mg of tixagevimab and 150 mg of cilgavimab in kidney transplant recipients

Iliès Benotmane, Aurélie Velay, Gabriela Gautier-Vargas, +13

American Journal of Transplantation

TransplantationKidney TransplantKidney TransplantationTransplantation MedicineKidney Transplant Recipients +4

A fourth dose of the mRNA-1273 SARS-CoV-2 vaccine improves serum neutralization against the Delta variant in kidney transplant recipients

Iliès Benotmane, Timothée Bruel, Delphine Planas, +3

Kidney International

VaccinationTransplantationVaccine DevelopmentKidney TransplantFourth Dose +6

Intravenous immunoglobulin as a preventive strategy against BK virus viremia and BKV-associated nephropathy in kidney transplant recipients—Results from a proof-of-concept study

Iliès Benotmane, Morgane Solis, Aurélie Velay, +10

American Journal of Transplantation